---
title: "Relativity Acquisition Corp. Shareholders Approve Business Combination with Instinct Brothers | ACQC Stock News"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/280379979.md"
description: "Relativity Acquisition Corp. Shareholders Approve Business Combination with Instinct Brothers | ACQC Stock News"
datetime: "2026-03-24T15:00:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280379979.md)
  - [en](https://longbridge.com/en/news/280379979.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280379979.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/280379979.md) | [English](https://longbridge.com/en/news/280379979.md)


# Relativity Acquisition Corp. Shareholders Approve Business Combination with Instinct Brothers | ACQC Stock News

Relativity Acquisition Corp. Shareholders Approve Business Combination with Instinct Brothers | ACQC Stock News

### 相關股票

- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [SPAC & New Issue ETF (SPCX.US)](https://longbridge.com/zh-HK/quote/SPCX.US.md)
- [Plum Acquisition Corp III (PLMJ.US)](https://longbridge.com/zh-HK/quote/PLMJ.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [Direxion S&P Biotech Bull 3X (LABU.US)](https://longbridge.com/zh-HK/quote/LABU.US.md)
- [Tiga Acquisition Corp. II (TTO.US)](https://longbridge.com/zh-HK/quote/TTO.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [RF ACQUISITION CORP II COM USD0.0001 (S/R 01/05/2026) (RFAIR.US)](https://longbridge.com/zh-HK/quote/RFAIR.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md)

## 相關資訊與研究

- [09:00 ETDelonix Bioworks Announces Initiation of Phase 1 First-in-Human Clinical Trial of a Next-Generation MenB OMV Vaccine DX-104](https://longbridge.com/zh-HK/news/281025352.md)
- [Merck's Enlicitide Decanoate Shows Greater LDL-C Reduction Than Oral Non-Statins At 8 Weeks](https://longbridge.com/zh-HK/news/281051985.md)
- [Ultragenyx clears IND for UX016 to advance Phase 1/2 GNEM study funded by patient group](https://longbridge.com/zh-HK/news/281024362.md)
- [Teva Pharmaceutical Gets US FDA Approval for Prolia Biosimilar; Xoliar Biosimiliar Applications Accepted in US, Europe](https://longbridge.com/zh-HK/news/281026919.md)
- [09:35 ETHengrui Pharma and Braveheart Bio Announce Positive Phase 2 Results with HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy](https://longbridge.com/zh-HK/news/281030940.md)